Paul Sanger interviewed Damian Spring, CEO of Santana Minerals Limited (ASX:SMI), to discuss the Bendigo gold project, which has recently been designated as a fast-track project. Damian highlighted the project's economic potential, projecting 1.1 million ounces of gold over ten years, which could generate significant export earnings and job creation in New Zealand. He mentioned ongoing environmental studies and a feasibility study set for release soon, emphasising the positive impact of rising gold prices on profitability and investor interest.
Copyright 2024 – Finance News Network
17 May 2024 - Elementos Limited (ASX:ELT) Managing Director Joe David discusses the recommencement of DFS and licensing activities following discussions with the Andalusian government.
16 May 2024 - Glenn Corrie, CEO of Hazer Group, speaks about their groundbreaking low-emission hydrogen and graphite production technology, recent achievements, and future plans for commercialization and global expansion.
05 Nov 2021 - BrainChip Holdings Limited (ASX:BRN) Vice President of Worldwide Sales and Marketing Rob Telson talks about the company and the future of artificial intelligence.
02 Mar 2023 - Scott Kelly, RAM CEO Australia, provides an introduction to the RAM Essential Services Property Fund (ASX:REP), discussing geographical spread, yield, investment strategy, financials and inflation.
21 Sep 2023 - Thomas Nador - CEO - Buru Energy (ASX:BRU) is an oil and gas producer and explorer with its core area of activity in the in the northwest Western Australia in the onshore Canning Basin. The Company is also actively participating in the new energy economy with interests in natural hydrogen, CCS and battery minerals.
29 Jan 2021 - Cyclopharm (ASX:CYC) CEO & Managing Director, James McBrayer talks about its recent cap raising to support rapid USA commercialisation for Technegas following USFDA approval targeted in Q2 2021.
28 Sep 2020 - Cyclopharm Limited (ASX:CYC) Managing Director and CEO James McBrayer provides an update on the company's US Phase 3 trial for Technegas, and USFDA approval process timeline, with commercial sales expected in the US for 2021.
17 Dec 2019 - Integrated Payment Technologies (ASX:IP1) CEO, Dean Martin discusses its payments solutions ClickSuper and PayVu, industry tailwinds, new features and platform integration.
